Project - Benchmarking genomics and health biotechnology in seven developing countries, 1991-2002 - Brazil, Cuba, China, Egypt, India, Republic of Korea and South Africa
Client - University of Toronto (UofT) - Joint Centre for Bioethics (JCB)
Description - The Joint Centre for Bioethics (JCB) of the University of Toronto (UofT) commissioned Science-Metrix to measure the scientific activity of seven developing countries in the fields of genomics and biotechnologies. This mandate is part of a project called Genome Innovation Systems in Developing Countries, an initiative of the Canadian Program on Genomics and Global Health of the JCB. The project is interdisciplinary and involves collaboration with local stakeholders. It analyzes innovation systems in genomics and biotechnologies in the following developing countries: Brazil, Cuba, China, Egypt, India, Republic of Korea and South Africa. Science-Metrix produced a scientometric study providing a precise picture of the dynamics of the targeted countries’ scientific publications. Covering a period of twelve years (1991-2002), the report describes the evolution of genomics and health biotechnologies in developed and developing countries, on the international and national levels. Science-Metrix processed and normalized scientific papers on genomics and biotechnologies retrieved from Thomson ISI’s Science Citation Index Expanded (SCI) using a keyword search method. Comparisons were drawn between the performance of developed countries using five scientometric indicators and a multicriteria analysis including the number of publications, the mean relative impact factor, the specialization index and the relative number of citations as well as the networks of national and international collaborators. For each of the seven countries, the report also presents a scientometric analysis by economic sectors, by cities, by institutions and by scientists.
Over the past few years, the number of annual publications in genomics and health biotechnologies has reached a plateau at the international level and is decreasing in the most active developed countries. However, some developing countries are rapidly increasing their output in the field and their presence is increasingly important within the international scientific community. The Republic of Korea and China currently show very high growth rates (more than 20% between 1999 and 2002) and could even overtake some G12 countries (such as Spain and Switzerland) in genomics and health biotechnologies in the years to come.
Bertrand F. and Côté G. 2004.
Benchmarking genomics and health biotechnology in seven developing countries, 1991-2002 - Brazil, Cuba, China, Egypt, India, Republic of Korea and South Africa. Prepared for the University of Toronto Joint Center for Bioethics (JCB) by Science-Metrix, 78 pages.
[PDF]
|
